MX2016008884A - Formas solidas de tenofovir. - Google Patents
Formas solidas de tenofovir.Info
- Publication number
- MX2016008884A MX2016008884A MX2016008884A MX2016008884A MX2016008884A MX 2016008884 A MX2016008884 A MX 2016008884A MX 2016008884 A MX2016008884 A MX 2016008884A MX 2016008884 A MX2016008884 A MX 2016008884A MX 2016008884 A MX2016008884 A MX 2016008884A
- Authority
- MX
- Mexico
- Prior art keywords
- tenofovir
- solid forms
- forms
- solid
- isolation
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 2
- 229960004556 tenofovir Drugs 0.000 title abstract 2
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 title abstract 2
- 238000002955 isolation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
La presente invención se relaciona con formas sólidas de tenofovir y métodos para preparación, uso y aislamiento de estas formas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461927617P | 2014-01-15 | 2014-01-15 | |
| PCT/US2015/010831 WO2015108780A1 (en) | 2014-01-15 | 2015-01-09 | Solid forms of tenofovir |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016008884A true MX2016008884A (es) | 2016-09-16 |
Family
ID=52434978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016008884A MX2016008884A (es) | 2014-01-15 | 2015-01-09 | Formas solidas de tenofovir. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9487546B2 (es) |
| EP (1) | EP3094637B1 (es) |
| JP (2) | JP2017507914A (es) |
| KR (1) | KR20160099655A (es) |
| CN (1) | CN105960409A (es) |
| AR (1) | AR099082A1 (es) |
| AU (1) | AU2015206758B2 (es) |
| CA (1) | CA2935965A1 (es) |
| EA (1) | EA031174B1 (es) |
| ES (1) | ES2762783T3 (es) |
| HK (1) | HK1223624A1 (es) |
| IL (1) | IL246569A0 (es) |
| MX (1) | MX2016008884A (es) |
| NZ (1) | NZ721832A (es) |
| PL (1) | PL3094637T3 (es) |
| PT (1) | PT3094637T (es) |
| SG (1) | SG11201605415RA (es) |
| SI (1) | SI3094637T1 (es) |
| TW (1) | TWI660965B (es) |
| WO (1) | WO2015108780A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202105371YA (en) | 2014-12-26 | 2021-07-29 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| CN106380484A (zh) * | 2016-08-29 | 2017-02-08 | 杭州百诚医药科技股份有限公司 | 一种替诺福韦艾拉酚胺的新晶型及其制备方法 |
| FI3706762T3 (fi) | 2017-12-07 | 2024-12-13 | Univ Emory | N4-hydroksisytidiini ja johdannaisia sekä niihin liittyviä virusten vastaisia käyttötapoja |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057305A (en) | 1992-08-05 | 2000-05-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Antiretroviral enantiomeric nucleotide analogs |
| WO1998004569A1 (en) * | 1996-07-26 | 1998-02-05 | Gilead Sciences, Inc. | Nucleotide analogs |
| US5922695A (en) | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
| US5935946A (en) | 1997-07-25 | 1999-08-10 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
| OA12393A (en) * | 2000-07-21 | 2006-04-18 | Gilead Sciences Inc | Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same. |
| SI1583542T1 (sl) | 2003-01-14 | 2008-12-31 | Gilead Sciences Inc | Sestavki in postopki za kombinacijsko antivirusnoterapijo |
| WO2008007392A2 (en) * | 2006-07-12 | 2008-01-17 | Matrix Laboratories Limited | Process for the preparation of tenofovir |
| WO2010071216A1 (en) * | 2008-12-17 | 2010-06-24 | Eisai R&D Management Co., Ltd. | Polymorphic crystal of donepezil and process for producing the same |
| ZA201103820B (en) * | 2010-12-13 | 2012-01-25 | Laurus Labs Private Ltd | Process for the preparation of tenofovir |
| ES2608871T5 (es) * | 2011-08-16 | 2024-04-04 | Gilead Sciences Inc | Alafenamide hemifumarate de tenofovir |
| AR088109A1 (es) | 2014-04-11 | 2014-05-07 | Gilead Sciences Inc | Metodo para preparar analogos nucleotidicos antivirales |
| WO2013072745A1 (en) * | 2011-11-16 | 2013-05-23 | Laurus Labs Private Limited | Process for the preparation of tenofovir |
| CN103374038B (zh) * | 2012-04-11 | 2016-04-13 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种抗病毒药物的制备方法 |
| CN102899367B (zh) * | 2012-09-24 | 2014-04-30 | 常州大学 | 一种生物法和化学法结合合成泰诺福韦的方法 |
| CN103641758B (zh) * | 2013-11-19 | 2016-03-30 | 重庆紫光化工股份有限公司 | 廉价的高纯度的d,l-蛋氨酸的制备方法 |
-
2014
- 2014-12-12 TW TW103143442A patent/TWI660965B/zh active
-
2015
- 2015-01-09 CA CA2935965A patent/CA2935965A1/en not_active Abandoned
- 2015-01-09 NZ NZ721832A patent/NZ721832A/en unknown
- 2015-01-09 EA EA201691203A patent/EA031174B1/ru not_active IP Right Cessation
- 2015-01-09 MX MX2016008884A patent/MX2016008884A/es unknown
- 2015-01-09 SI SI201530958T patent/SI3094637T1/sl unknown
- 2015-01-09 PL PL15701877T patent/PL3094637T3/pl unknown
- 2015-01-09 HK HK16111943.7A patent/HK1223624A1/zh unknown
- 2015-01-09 EP EP15701877.1A patent/EP3094637B1/en active Active
- 2015-01-09 WO PCT/US2015/010831 patent/WO2015108780A1/en not_active Ceased
- 2015-01-09 SG SG11201605415RA patent/SG11201605415RA/en unknown
- 2015-01-09 PT PT157018771T patent/PT3094637T/pt unknown
- 2015-01-09 KR KR1020167019027A patent/KR20160099655A/ko not_active Ceased
- 2015-01-09 US US14/593,556 patent/US9487546B2/en active Active
- 2015-01-09 JP JP2016545902A patent/JP2017507914A/ja not_active Withdrawn
- 2015-01-09 CN CN201580004462.3A patent/CN105960409A/zh active Pending
- 2015-01-09 AU AU2015206758A patent/AU2015206758B2/en active Active
- 2015-01-09 ES ES15701877T patent/ES2762783T3/es active Active
- 2015-01-13 AR ARP150100078A patent/AR099082A1/es unknown
-
2016
- 2016-07-03 IL IL246569A patent/IL246569A0/en unknown
- 2016-10-05 US US15/285,924 patent/US20170056424A1/en not_active Abandoned
-
2017
- 2017-11-29 JP JP2017228998A patent/JP2018030884A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EA201691203A1 (ru) | 2016-12-30 |
| SI3094637T1 (sl) | 2019-12-31 |
| EP3094637A1 (en) | 2016-11-23 |
| JP2018030884A (ja) | 2018-03-01 |
| TW201609780A (zh) | 2016-03-16 |
| AU2015206758B2 (en) | 2017-11-30 |
| PL3094637T3 (pl) | 2020-04-30 |
| KR20160099655A (ko) | 2016-08-22 |
| US20170056424A1 (en) | 2017-03-02 |
| ES2762783T3 (es) | 2020-05-25 |
| US20150197535A1 (en) | 2015-07-16 |
| NZ721832A (en) | 2017-09-29 |
| AR099082A1 (es) | 2016-06-29 |
| US9487546B2 (en) | 2016-11-08 |
| AU2015206758A1 (en) | 2016-07-21 |
| CA2935965A1 (en) | 2015-07-23 |
| EA031174B1 (ru) | 2018-11-30 |
| EP3094637B1 (en) | 2019-10-16 |
| HK1223624A1 (zh) | 2017-08-04 |
| IL246569A0 (en) | 2016-08-31 |
| JP2017507914A (ja) | 2017-03-23 |
| PT3094637T (pt) | 2019-12-12 |
| SG11201605415RA (en) | 2016-07-28 |
| CN105960409A (zh) | 2016-09-21 |
| TWI660965B (zh) | 2019-06-01 |
| WO2015108780A1 (en) | 2015-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004557B (en) | Modulatory polynucleotides | |
| PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
| PH12018500711A1 (en) | Anti-pd1 antibodies and methods of use | |
| PH12017500877B1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
| MY202415A (en) | Subcutaneous formulations of anti-cd38 antibodies and their uses | |
| PH12016501763A1 (en) | Multispecific antibodies | |
| MY193661A (en) | Anti-tim3 antibodies and methods of use | |
| MY192927A (en) | Fused bicyclic compounds for the treatment of disease | |
| SG10201902326XA (en) | Mk2 inhibitors and uses thereof | |
| MX2016015162A (es) | Anticuerpos anti - gpc3 e inmunoconjugados. | |
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| MX2017008456A (es) | Compuestos biciclicos fusionados para el tratamiento de enfermedades. | |
| MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
| MY191539A (en) | Streptococcal vaccine | |
| IN2013MU00848A (es) | ||
| MX394051B (es) | Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos de uso del mismo | |
| MX2017000527A (es) | Formulaciones de anticuerpos cristalinos. | |
| MX2021006003A (es) | Formulaciones de anticuerpos cristalinos. | |
| IN2014CH00840A (es) | ||
| SG10201908248PA (en) | Processes for preparing fluoroketolides | |
| MY167350A (en) | Fat-and-oil composition and chocolate | |
| IN2014CH00304A (es) | ||
| MX383313B (es) | Compuestos de quinolinilciclohexilpropanamida sustituidos y metodos mejorados para su preparacion | |
| NZ721832A (en) | Solid forms of tenofovir | |
| PH12018501166B1 (en) | Concentrated gibberellin solution formulations |